德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02526 德适-B

未开盘 09-25 16:08:14

360.000

-40.000

-10.00%

最高385.000	最低347.400	成交量5.73万
今开385.000	昨收400.000	日振幅9.40%
总市值319.97亿	流通市值319.97亿	总股本8,888万
成交额2,052万	换手率0.06%	流通股本8,888万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"德适-B","latestPrice":360,"timestamp":1790323694003,"preClose":400,"halted":0,"volume":57300,"delay":0,"changeRate":-0.1,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"未开盘","change":-40,"latestTime":"09-25 16:08:14","open":385,"high":385,"low":347.4,"amount":20517965,"amplitude":0.094,"askPrice":360.2,"askSize":350,"bidPrice":360,"bidSize":750,"shortable":3,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":0,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":400,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0.7363145715217312,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02526/tweets","defaultTab":"tweets","newsList":[{"id":"2668957971","title":"Tempus大涨之后，德适科技(02526)的AI4S价值正在被重新发现","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957971","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668957971?lang=zh_cn&edition=full","pubTime":"2026-09-19 09:12","pubTimestamp":1789780357,"startTime":"0","endTime":"0","summary":"同日德适收涨0.39%。Tempus的经营数据给出了线索。沿着这条线研究德适，可以看到一家更接近AI4S本质的公司。iMedLoop于7月上线，晚于上半年报告期。德适正在构建AI4S看重的“发现问题—组织数据—训练模型—验证效果—重新交付”闭环。Tempus的行情提醒市场，高质量医学数据进入真实工作流并产生商业回报，才更有基础获得更高定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","07666","02526","BK1161","BK1100","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668732089","title":"德适生物：从两亿市场里长出来的 “医学影像大模型第一股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2668732089","media":"晚点LatePost","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668732089?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:18","pubTimestamp":1789733880,"startTime":"0","endTime":"0","summary":"两亿赛道、一张三类证、19 种影像模态、和一个大模型第一股的标签。文丨胡昊作为 “国内医学影像大模型第一股” 的德适生物，于今年 3 月底登陆港股，和智谱、MiniMax 一并进入港股的大模型叙事里；但德适在招股书中对自己的定位则朴素很多，就是一家做医学影像产品和服务的医疗器械公司。当然，这也不是德适的问题，而是医学影像行业整体的进入难度问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3Mjk1OTQ0Ng==&mid=2247538873&idx=2&sn=35b829733785ae9aa81b215e6cb0324c&chksm=fd2a3f0d9eb27e414f0c8bd45c4606940ccbbe5bd1830273d5d6ab755f83ba7eea55b76b9e70&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02251","02526","BK1189","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668951490","title":"【券商聚焦】开源证券维持德适-B（02526）买入评级 指影像AI合作拓商业化空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2668951490","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668951490?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:36","pubTimestamp":1789627014,"startTime":"0","endTime":"0","summary":"若基层医疗机构规模化接入，德适有望由传统软硬件及项目制收入向持续性的模型调用服务收入延伸，提升医疗影像AI商业模式的规模化及可复制性。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991863","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","QTOC","ARTY","KCE","VTHR","AGIX","02526","AIPO","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656224","title":"港股异动 | 德适-B(02526)最高涨超14% 与安诊儿订立合作框架协议 共同探索 “医疗数据资产化” 核心方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667656224?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:49","pubTimestamp":1789372174,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B最高涨超14%，截至发稿，涨7.25%，报509港元，成交额7412.57万港元。消息面上，9月11日，德适-B发布公告，本公司与浙江省安诊儿医学人工智能科技有限公司(安诊儿)订立合作框架协议，围绕医学影像人工智能、基层影像云服务及医疗数据产品开展合作，合作期限自签订之日起为三年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","BK4585","KCAI","BK1100","BK4588","VXUS","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667373036","title":"医疗AI如何从“看得准”走向“用得上”？德适-B(02526)与安诊儿探索区域协同新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2667373036","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667373036?lang=zh_cn&edition=full","pubTime":"2026-09-14 12:34","pubTimestamp":1789360485,"startTime":"0","endTime":"0","summary":"医疗影像AI正在进入一个与早期不同的发展阶段。智通财经APP获悉，9月11日，德适-B发布自愿性公告称，公司与浙江省安诊儿医学人工智能科技有限公司签订合作框架协议，合作期为三年。医疗AI进入临床，并不意味着完全替代医生。德适与安诊儿打造的分级影像服务模式，正是这一国际前沿理念的本土化落地标杆。德适与安诊儿的合作，双方将探索混合式数据协作架构，兼顾服务效率与数据安全。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","BK1100","150261"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639327","title":"港股公告掘金 | 中国生物制药拟44.8亿元向谢承润收购正大天晴5%股权 完成后间接持股增至65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639327","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667639327?lang=zh_cn&edition=full","pubTime":"2026-09-14 09:01","pubTimestamp":1789347690,"startTime":"0","endTime":"0","summary":"重大事项：中国生物制药(01177)拟44.8亿元向谢承润收购正大天晴5%股权 完成后间接持股增至65%俊知集团(01300)：拟4.55亿元收购青海中利光纤技术100%股权中国宏桥(01378)附属拟2.4亿元收购魏桥新创全部股权阜博集团(03738)旗下附属公司与蚂蚁数科订立合作协议 携手共建版权大模型中国派对文化(01532)拟出售浙江云游智慧文旅集团注册资本总额的32%德适-B(02526","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1506","BK1589","BK1191","BK4588","01300","BK4585","KCAI","BK1585","01177","BK1521","IE00BZ08YT58.USD","BK1149","BK1555","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","02526","01030","BK1100","BK1240","VXUS","03728","BK1148","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128209853","title":"德适-B（02526）与安诊儿签署三年合作框架协议 聚焦医学影像AI与云服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1128209853","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128209853?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:05","pubTimestamp":1789117548,"startTime":"0","endTime":"0","summary":"2026年9月11日，德适-B公告称，其全资母公司杭州德适生物科技股份有限公司已与浙江省安诊儿医学人工智能科技有限公司签订合作框架协议，合作期限自签约日起为三年。双方将在医学影像人工智能、基层影像云服务及医疗数据产品等领域展开合作。德适是一家以人工智能革新医疗诊断的科技企业，已建立 iMedImage 基座模型和 iMedLoop 医疗影像AI研究与生产加速平台。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666540988","title":"德适-B(02526)与安诊儿订立合作框架协议 围绕医学影像人工智能、基层影像云服务及医疗数据产品开展合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540988","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666540988?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:04","pubTimestamp":1789117465,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B 发布公告，本公司与浙江省安诊儿医学人工智能科技有限公司(安诊儿)订立合作框架协议，围绕医学影像人工智能、基层影像云服务及医疗数据产品开展合作，合作期限自签订之日起为三年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["OGIG","MFIG","QQA","AIQU","QQQ","NAPR","QDEC","AQGX","QMAR","161631","GPIQ","03034","DQJN","WPAI","FWD","GK","02251","VUSE","TARK","ARTY","NEWZ","PBOT","SQQQ","QLD","159891","QSWN","NJUL","MVPS","QQQX","CHAT","KOMP","NOCT","LCLG","TQQY","TECY","AIBU","CWC","QQQM","QTOC","QID","AGIX","AIFD","PSQ","CPNQ","07266","NBDS","NJAN","02526","TQQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114891005","title":"德适生物与浙江安贞儿医疗AI签署合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1114891005","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114891005?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:02","pubTimestamp":1789117360,"startTime":"0","endTime":"0","summary":"德适生物（DIAGENS-B）宣布，已与浙江安贞儿医疗AI技术公司正式签署合作框架协议。这一举措标志着双方将在医疗人工智能领域展开深度合作，共同探索技术创新与应用落地的新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191376663","title":"杭州德适生物科技：携手共建省级数字与智能影像能力基地","url":"https://stock-news.laohu8.com/highlight/detail?id=1191376663","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191376663?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:02","pubTimestamp":1789117354,"startTime":"0","endTime":"0","summary":"杭州德适生物科技股份有限公司近日宣布，将与相关合作方共同打造一个省级数字与智能影像能力基地。此举旨在整合多方资源，推动该领域的技术创新与产业升级。该基地的建设聚焦于数字与智能影像方向，其核心目标在于提升区域内的研发实力与应用水平。从战略层面看，此次合作标志着德适生物在夯实其核心业务的同时，正积极向价值链上游及更广阔的数字化生态延伸。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121862311","title":"德适-B(02526)将于9月30日召开临时股东会 审议2026年股份激励计划及10%授股授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1121862311","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121862311?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:42","pubTimestamp":1789033375,"startTime":"0","endTime":"0","summary":"德适-B于9月10日发布公告，拟于2026年9月30日（星期三）上午10时在浙江省杭州市临平区红丰路609号A幢9楼1号会议室举行2026年第二次临时股东大会。届时股东将就以下主要议案进行表决：。股权登记日为2026年9月25日，股份过户登记将于9月25日至9月30日暂停办理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301565","title":"港股异动 | 德适-B(02526)涨超10% 模型服务爆发式增长 业绩兑现度行业领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301565","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666301565?lang=zh_cn&edition=full","pubTime":"2026-09-09 11:03","pubTimestamp":1788922983,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B盘中涨超10%，截至发稿，涨8.85%，报472.4港元，成交额1176万港元。2026年中报显示，德适上半年实现营收1.087亿元，同比增长21.0%；其中模型服务收入达9454.1万元，同比大幅增长101.1%，占总收入比重升至86.9%。在多数港股AI应用标的仍处于 “概念验证、收入微薄” 的阶段，德适已经用近九成的收入占比，验证了商业模式的可行性，业绩兑现度在板块内处于领先水平，符合 “营收增速环比提速” 的核心选股框架。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VXUS","BK4585","KCAI","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393286","title":"德适-B（02526）扬升21.27% 今起正式调入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393286","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665393286?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:54","pubTimestamp":1788746078,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德适-B 盘初股价扬升21.27%，最新报601.00港元，成交额1832.61万港元。消息面上，根据上交所上周五通知，德适-B正式调入港股通标的证券名单，该调整将于9月7日（周一）起生效。另一消息面上，开源证券新近研究指，公司积极布局iMedImage医学影像基座大模型，推动业务模式由传统医学影像软件向AI医疗平台升级。公司有望受益于AI医疗渗透率提升及大模型应用落地。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990809","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","FLHK","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665363405","title":"港股AI应用怎么选？德适-B：高增速+强壁垒的垂直AI稀缺标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2665363405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665363405?lang=zh_cn&edition=full","pubTime":"2026-09-06 07:20","pubTimestamp":1788650457,"startTime":"0","endTime":"0","summary":"在垂直AI赛道中，医疗影像 AI 是兼具短期业绩与长期空间的优质细分赛道。德适-B  正是港股医疗AI赛道中，完美契合 “高增速 + 强壁垒 + 催化明确” 选股标准的稀缺标的。一是纳入港股通于 9 月 7 日正式生效。回到港股 AI 应用的选股逻辑，行情走到当下，纯概念炒作的阶段已经过去，资金越来越向有业绩、有壁垒、有催化的标的集中。","market":"hk","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492444.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QTOC","VTHR","AIQ","02526","CHAT","KCAI","AIPO","BK1100","ARTY","BK4585","BK4588","VXUS","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664317103","title":"德适-B(02526)正式纳入港股通 打开内地投资者参与通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664317103","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664317103?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:17","pubTimestamp":1788524274,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，上交所9月4日盘后发布通知，根据《上海证券交易所沪港通业务实施办法》有关规定，德适-B(02526)正式调入港股通标的证券名单，该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖德适，正式解锁南向资金。9月2日，德适与香港理工大学正式揭牌成立“理大-德适科技通用人工智能与医学应用联合实验室”，双方将围绕医学影像分析、医疗基础大模型构建、医疗研发流程自动化等方向开展长期科研攻关，推动 AI for Science 在医疗领域的产学研转化，促进科研成果链接内地、香港乃至全球创新网络。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FLHK","02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881763","title":"港股概念追踪 | 恒生综合指数季检生效在即 把握被动资金布局、入通机遇(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881763","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664881763?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:04","pubTimestamp":1788483874,"startTime":"0","endTime":"0","summary":"截至2026年6月底，被动式追踪恒生指数系列的产品资产管理总值约为1066亿美元。股票获纳入恒生综合指数后，届时沪深交易所会相应调整港股通可投资标的范围，将直接影响港股通可投资范围，这是本次调整最大的二级效应。按港股通调整规则，被纳入恒生综合指数是成为港股通可交易标的的重要基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1116","03277","BK1183","BK1179","06106","BK4585","KCAI","BK1100","06656","BK1216","HK0000500386.USD","HK0000252160.HKD","00600","BK1163","BK4588","VXUS","HK0000252152.HKD","HSCI","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664911198","title":"港股异动 | 德适-B(02526.HK)涨超9% 纳入恒生综合指数9月7日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2664911198","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664911198?lang=zh_cn&edition=full","pubTime":"2026-09-02 14:58","pubTimestamp":1788332310,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02526","HSCI","BK4585","BK1100","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146552331","title":"德适-B2026年8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1146552331","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146552331?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:36","pubTimestamp":1788251819,"startTime":"0","endTime":"0","summary":"杭州德适生物科技股份有限公司（股票简称：德适-B，股票代码：02526）于2026年9月1日披露2026年8月股份变动月报表。公告显示，截至2026年8月31日，公司已发行的普通股H股总数为88,879,200股，与上月末持平，股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662053400","title":"德适-B午前涨超9% 开源证券首次覆盖给予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662053400","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662053400?lang=zh_cn&edition=full","pubTime":"2026-08-28 11:42","pubTimestamp":1787888520,"startTime":"0","endTime":"0","summary":"模拟交易客户端德适-B午前涨超9%，截至发稿，股价上涨9.02%，现报476.40港元，成交额2231.33万港元。公司已符合被纳入港股通交易的标准，且德适是本次指数调整中唯一获纳入恒生生物科技指数的公司，标志着市场对其在AI赋能医疗领域技术实力与行业地位的高度认可。开源证券发布研报称，德适积极布局iMedImage医学影像基座大模型，推动业务模式由传统医学影像软件向AI医疗平台升级。预计公司2026-2028年营业收入分别为4.9/9.3/17.2亿元，首次覆盖给予“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-28/doc-inipvvzx5693303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058765","title":"港股异动 | 德适-B(02526)早盘涨近9% 公司获纳入23个恒生指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058765","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662058765?lang=zh_cn&edition=full","pubTime":"2026-08-28 10:47","pubTimestamp":1787885232,"startTime":"0","endTime":"0","summary":"消息面上，德适已获恒生指数有限公司纳入23个恒生指数的成分股，包括恒生综合指数和恒生生物科技指数，自9月7日和9月14日起生效，以及恒生港股通人工智能主题指数，亦自9月14日起生效。公司已符合被纳入港股通交易的标准，且德适是本次指数调整中唯一获纳入恒生生物科技指数的公司，标志着市场对其在AI赋能医疗领域技术实力与行业地位的高度认可。值得注意的是，德适2025年营收1.64亿元，意味着该机构预期公司收入三年翻十倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 德适-B(02526)早盘涨近9% 公司获纳入23个恒生指数","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.diagens.com","stockEarnings":[{"period":"1week","weight":-0.1667},{"period":"1month","weight":-0.3233},{"period":"3month","weight":0.204},{"period":"6month","weight":2.6364},{"period":"ytd","weight":2.6364}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州德适生物科技股份有限公司(简称“德适生物”),是全球医学影像AI与医疗影像装备领域的领先企业,业务覆盖全球市场。依托自主研发的通用医学影像基座模型iMedImage,公司成功打造出多元化的智能装备及配套产品矩阵,包括AutoVision染色体核型分析系统、MetaSight自动细胞显微图像扫描系统、KayoFlow自动细胞收获仪与制片染色一体机等,可满足临床多场景需求。公司客户已覆盖全国400多家医疗保健中心与医疗机构,获得市场广泛认可。未来,公司将持续为全球客户提供标准化智能成像设备、模型即服务(MaaS)云平台及本地化自训练解决方案,以技术创新提升医学影像诊断的效率、准确率与可及性,引领全球医学影像行业进入智能化时代。","exchange":"SEHK","name":"德适-B","nameEN":"DIAGENS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德适-B,02526,德适-B股票,德适-B股票老虎,德适-B股票老虎国际,德适-B行情,德适-B股票行情,德适-B股价,德适-B股市,德适-B股票价格,德适-B股票交易,德适-B股票购买,德适-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}